| # | Title | Journal | Year | Citations |
|---|
| 1 | Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis | Kidney and Blood Pressure Research | 2017 | 1,821 |
| 2 | Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study | Annals of the Rheumatic Diseases | 2014 | 633 |
| 3 | Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2018 | 555 |
| 4 | ESC working group position paper on myocardial infarction with non-obstructive coronary arteries | European Heart Journal | 2017 | 511 |
| 5 | Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure | Nature Communications | 2020 | 466 |
| 6 | Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis | Frontiers in Immunology | 2019 | 376 |
| 7 | Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding | European Respiratory Journal | 2013 | 361 |
| 8 | Risk factors for chronic thromboembolic pulmonary hypertension | European Respiratory Journal | 2008 | 336 |
| 9 | Diastolic Pulmonary Vascular Pressure Gradient | Chest | 2013 | 334 |
| 10 | The Effect of Coenzyme Q 10 on Morbidity and Mortality in Chronic Heart Failure | JACC: Heart Failure | 2014 | 326 |
| 11 | Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction | Circulation | 2013 | 286 |
| 12 | Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis | Circulation | 2005 | 265 |
| 13 | Refining the prognostic impact of functional mitral regurgitation in chronic heart failure | European Heart Journal | 2018 | 261 |
| 14 | Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML | American Journal of Hematology | 2011 | 254 |
| 15 | PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease) | Journal of the American College of Cardiology | 2013 | 253 |
| 16 | Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors | Blood | 2015 | 239 |
| 17 | COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel | European Heart Journal Cardiovascular Imaging | 2020 | 237 |
| 18 | Platelet Physiology | Seminars in Thrombosis and Hemostasis | 2016 | 233 |
| 19 | Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival | American Journal of Respiratory and Critical Care Medicine | 2015 | 217 |
| 20 | Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1) | Chest | 2014 | 214 |
| 21 | Gender differences in the effects of cardiovascular drugs | European Heart Journal - Cardiovascular Pharmacotherapy | 2017 | 204 |
| 22 | Cardiovascular disease risk reduction by raising HDL cholesterol – current therapies and future opportunities | British Journal of Pharmacology | 2012 | 203 |
| 23 | Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis | Journal of the American College of Cardiology | 2021 | 187 |
| 24 | Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality | Heart | 2015 | 181 |
| 25 | Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome | European Heart Journal | 2020 | 167 |
| 26 | Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis | Hepatology | 2012 | 158 |
| 27 | Coagulation parameters and major bleeding in critically ill patients with cirrhosis | Hepatology | 2016 | 148 |
| 28 | Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature | Journal of Molecular and Cellular Cardiology | 2013 | 145 |
| 29 | Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony | European Heart Journal | 2007 | 144 |
| 30 | Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients | Scientific Reports | 2021 | 144 |
| 31 | Detection of molecular targets on the surface of CD34+/CD38− stem cells in various myeloid malignancies | Leukemia and Lymphoma | 2006 | 140 |
| 32 | Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo | Atherosclerosis | 2006 | 137 |
| 33 | Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic Plaques | Arteriosclerosis, Thrombosis, and Vascular Biology | 2011 | 137 |
| 34 | Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients | Aging | 2015 | 132 |
| 35 | Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue | International Journal of Obesity | 2013 | 131 |
| 36 | Daptomycin: A Review 4 Years after First Approval | Pharmacology | 2008 | 130 |
| 37 | Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis | European Heart Journal | 2005 | 129 |
| 38 | Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation | Value in Health | 2013 | 127 |
| 39 | Dendritic cells in atherosclerotic disease | Clinical Immunology | 2010 | 120 |
| 40 | Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial | Lancet Respiratory Medicine,the | 2019 | 116 |
| 41 | Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial | Atherosclerosis | 2011 | 114 |
| 42 | The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics | European Journal of Heart Failure | 2016 | 114 |
| 43 | Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume | European Heart Journal | 2008 | 113 |
| 44 | Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology | European Heart Journal - Cardiovascular Pharmacotherapy | 2018 | 113 |
| 45 | Complement in atherosclerosis: friend or foe? | Journal of Thrombosis and Haemostasis | 2011 | 111 |
| 46 | Global Chronic Total Occlusion Crossing Algorithm | Journal of the American College of Cardiology | 2021 | 111 |
| 47 | Oxidized Phospholipids Are More Potent Antagonists of Lipopolysaccharide than Inducers of Inflammation | Journal of Immunology | 2010 | 110 |
| 48 | High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality | European Heart Journal | 2013 | 110 |
| 49 | Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site | Leukemia | 2017 | 110 |
| 50 | Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology | European Heart Journal | 2016 | 109 |
